p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study
Martin Köbel(University of Calgary), Jaime Lesnock(University of California, Los Angeles), Angela Brooks‐Wilson(BC Cancer Agency), Nicola S. Meagher(The University of Sydney), Esther Elishaev(University of Pittsburgh), Penny Coulson(Institute of Cancer Research), Michael E. Carney(The University of Texas MD Anderson Cancer Center), Kara L. Cushing‐Haugen(Fred Hutch Cancer Center), Michael E. Jones(Institute of Cancer Research), Michael S. Anglesio(University of British Columbia), Christiani Bisinotto(Universidade de São Paulo), Brenda Y. Hernandez(Cancer Center of Hawaii), Gregg Nelson(Brigham and Women's Hospital), Marjorie J. Riggan(Duke Medical Center), Andreas D. Hartkopf(University of Tübingen), C. Blake Gilks(Vancouver General Hospital), Helena Gronwald(Pomeranian Medical University), Ashley Weir(The University of Melbourne), Peter Rambau(Catholic University of Health and Allied Sciences), M.M. Boisen(University of Pittsburgh), Matthias W. Beckmann(Universitätsklinikum Erlangen), Prafull Ghatage(University of Calgary), Simon A. Gayther(The University of Texas Health Science Center at Houston), Arántzazu Barquín(Hospital Universitario HM Sanchinarro), Catherine J. Kennedy(The University of Sydney), Aleksandra Gentry‐Maharaj(UCL Australia), Joy Hendley(Peter MacCallum Cancer Centre), Eunyoung Kang(University of Calgary), Suha Deen(Nottingham University Hospitals NHS Trust), Anna Fischer(University of Tübingen), Anna Jakubowska(Pomeranian Medical University), Sián Fereday(Peter MacCallum Cancer Centre), Jessica Boros(The University of Sydney), Holly R. Harris(Fred Hutch Cancer Center), Madeleine Courtney‐Brooks(University of Virginia Health System), Marcel Grube(University of British Columbia), Mona El‐Bahrawy(Al-Azhar University), Jennifer M. Koziak(Alberta Health Services), Paul R. Harnett(The University of Sydney), Alison H. Brand(The University of Sydney), Tomasz Kluz(University of Rzeszów), Alexander Hein, Cezary Cybulski(International Hereditary Cancer Center), Ramona Erber(Friedrich-Alexander-Universität Erlangen-Nürnberg), Cheng‐Han Lee(National Tsing Hua University), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Mercedes Jimenez‐Liñan(University of Kansas), Yajue Huang(Mayo Clinic), Jennifer Alsop(Manchester Academic Health Science Centre)
Cited by 29
Related Papers
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency
|Nature Genetics|1999|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes
|The American Journal of Human Genetics|2018|1.2k